Abstract: The present application discloses a THLW peptide, an amino acid sequence of which is represented by SEQ ID No. 1. The THLW peptide can be used as a biomarker for diseases, such as oral cancer and cervical cancer, etc., relating to infection of human papilloma virus (HPV), therefore, THLW peptide as an antigen or an anti-THLW peptide antibody prepared can be used to detect the risk of developing cancer for sample providers.
Type:
Grant
Filed:
October 25, 2017
Date of Patent:
August 13, 2019
Assignees:
TUNGCHAI UNIVERSITY, TAICHUNG VETERANS GENERAL HOSPITAL